Aurum Biosciences has develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need.
Business Model:
Revenue: $13.2M
Employees: 51-200
Address: 20 23 Woodside Place
City: Glasgow City
State: scotland
Zip: G3 7QF
Country: GB
AURUM Biosciences Ltd develops novel pharmaceuticals for use in a number of different clinical indications of high unmet medical need. Aurum is currently completing preclinical development of ABL101, its lead stroke management product, and envisages initiating clinical studies of efficacy and safety in the near future. Follow-on programmes include products for heart disease, cancer, epilepsy, and dementia. Aurum’s lead project utilises an oxygen carrier and proprietary software for use with MRI in Acute Ischaemic Stroke. Aurum has funding in place to initiate recruitment for a Phase 2 clinical study in stroke patients.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 10/2020 | Funding Round | 4 | $875.3k |
Infinion Biopharma Scottish Health Innovations Scottish Investment Bank TRICAPITAL Infinion Biopharma Scottish Health Innovations Scottish Investment Bank TRICAPITAL |
11/2015 | Funding Round | 2 | $4.6M |
Scottish Investment Bank TRICAPITAL Scottish Investment Bank TRICAPITAL |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|